Albireo Weighted Average Shares Diluted from 2010 to 2023

Summary

ALBODelisted Stock

USD 44.15 0.75 1.67%

Albireo Pharma Weighted Average Shares Diluted yearly trend continues to be very stable with very little volatility. Weighted Average Shares Diluted is likely to grow to about 23.8 M this year. During the period from 2010 to 2023, Albireo Pharma Weighted Average Shares Diluted quarterly data regression pattern had range of 23,583,464 and median of 7,819,302. Albireo Pharma Weighted Average Shares is very stable at the moment as compared to the past year. Albireo Pharma reported last year Weighted Average Shares of 22.1 Million. As of 26th of March 2023, Weighted Average Shares Diluted is likely to grow to about 23.8 M, while Consolidated Income is likely to drop (33 M).

Check Albireo Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Albireo main balance sheet or income statement drivers, such as Direct Expenses of 1.2 M, Cost of Revenue of 1.2 M or Gross Profit of 48.7 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0502, PPandE Turnover of 67.56 or Receivables Turnover of 6.79. Albireo financial statements analysis is a perfect complement when working with Albireo Pharma Valuation or Volatility modules. It can also supplement various Albireo Pharma Technical models . Check out Trending Equities.

Albireo Weighted Average Shares Diluted Breakdown

Showing smoothed Weighted Average Shares Diluted of Albireo Pharma with missing and latest data points interpolated. The weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPSDil]; determined based on the timing of issuance of shares or units in the period.Albireo Pharma's Weighted Average Shares Diluted historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Albireo Pharma's overall financial position and show how it may be relating to other accounts over time.

Weighted Average Shares Diluted

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Weighted Average Shares Diluted

Timeline

Albireo Weighted Average Shares Diluted Regression Statistics

	Arithmetic Mean	8,346,301
	Geometric Mean	2,637,732
	Coefficient Of Variation	108.32
	Mean Deviation	7,888,517
	Median	7,819,302
	Standard Deviation	9,040,620
	Range	23,583,464
	R-Value	0.94
	R-Squared	0.88
	Significance	0.00000078
	Slope	2,025,069

Albireo Weighted Average Shares Diluted History

	2023	23.8 M
	2022	22.1 M
	2021	19.2 M
	2020	16 M
	2019	12.4 M
	2018	11.7 M
	2017	7.8 M
	2016	1.2 M
	2014	265.6 K
	2013	713.5 K
	2012	521.7 K

About Albireo Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Albireo Pharma income statement, its balance sheet, and the statement of cash flows. Albireo Pharma investors use historical funamental indicators, such as Albireo Pharma's Weighted Average Shares Diluted, to determine how well the company is positioned to perform in the future. Although Albireo Pharma investors may use each financial statement separately, they are all related. The changes in Albireo Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Albireo Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Albireo Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Albireo Pharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for 2023
Weighted Average Shares Diluted	22.1 M	23.8 M
Average Assets	307 M	331.2 M
Average Equity	177.9 M	191.9 M
Invested Capital Average	-784.8 K	-846.8 K

Be your own money manager

Our tools can tell you how much better you can do entering a position in Albireo Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Focused Opportunities Now

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences

All Next

Launch Module

Check out Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Albireo Stock

If you are still planning to invest in Albireo Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Albireo Pharma's history and understand the potential risks before investing.

	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Bond Directory Find actively traded corporate debentures issued by US companies
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Piotroski F Score Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
	Bond Directory Find actively traded corporate debentures issued by US companies
	Share Portfolio Track or share privately all of your investments from the convenience of any device

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC